Egusa Hiroshi, Iida Keisuke, Kobayashi Munemasa, Lin Terry Y, Zhu Min, Zuk Patricia A, Wang Chiachien Jake, Thakor Devang K, Hedrick Marc H, Nishimura Ichiro
Jane and Jerry Weintraub Center for Reconstructive Biotechnology, Division of Advanced Prosthodontics, Biomaterials and Hospital Dentistry, UCLA School of Dentistry, Los Angeles, CA, USA.
Tissue Eng. 2007 Oct;13(10):2589-600. doi: 10.1089/ten.2007.0080.
Bone marrow- and adipose tissue-derived stromal cells (BMSCs and ASCs, respectively) exhibit a similar capacity for osteogenic differentiation in vitro, but it is unclear whether they share a common differentiation process, because they originate from different tissues. The aim of this study was to explore BMSC and ASC osteogenic differentiation by focusing on the expression of extracellular matrix-related genes (ECMGs), which play a crucial role in osteogenesis and bone tissue regeneration in vivo. We characterized the gene expression profiles of BMSCs and ASCs using a custom complementary deoxyribonucleic acid microarray containing 55 ECMGs. Undifferentiated BMSCs and ASCs actively expressed a wide range of ECMGs. Once BMSCs and ASCs were placed in an osteogenic differentiation medium, 24 and 17 ECMGs, respectively, underwent considerable downregulation over the course of the culture period. The remaining genes were maintained at a similar expression level to corresponding uninduced cell cultures. Although the suppression phenomenon was consistent irrespective of stromal cell origin, collagen (COL)2A1, COL6A1, COL9A1, parathyroid hormone receptor, integrin (INT)-beta3, and TenascinX genes were only downregulated in osteogenic BMSCs, whereas COL1A2, COL3A1, COL4A1, COL5A2, COL15A1, osteopontin, osteonectin, and INT-beta1 genes were only downregulated in osteogenic ASCs. During this time period, cell viability was sustained, suggesting that the observed downregulation did not occur by selection and elimination of unfit cells from the whole cell population. These data suggest that osteogenically differentiating BMSCs and ASCs transition away from a diverse gene expression pattern, reflecting their multipotency toward a configuration specifically meeting the requirements of the target lineage. This change may serve to normalize gene expression in mixed populations of stem cells derived from different tissues.
骨髓和脂肪组织来源的基质细胞(分别为BMSC和ASC)在体外表现出相似的成骨分化能力,但尚不清楚它们是否共享一个共同的分化过程,因为它们起源于不同的组织。本研究的目的是通过关注细胞外基质相关基因(ECMG)的表达来探索BMSC和ASC的成骨分化,这些基因在体内的骨生成和骨组织再生中起着关键作用。我们使用包含55个ECMG的定制互补脱氧核糖核酸微阵列对BMSC和ASC的基因表达谱进行了表征。未分化的BMSC和ASC积极表达多种ECMG。一旦将BMSC和ASC置于成骨分化培养基中,分别有24个和17个ECMG在培养期间经历了显著的下调。其余基因维持在与相应未诱导细胞培养物相似的表达水平。尽管无论基质细胞来源如何,抑制现象都是一致的,但胶原蛋白(COL)2A1、COL6A1、COL9A1、甲状旁腺激素受体、整合素(INT)-β3和腱生蛋白X基因仅在成骨BMSC中下调,而COL1A2、COL3A1、COL4A1、COL5A2、COL15A1、骨桥蛋白、骨连接蛋白和INT-β1基因仅在成骨ASC中下调。在此期间,细胞活力得以维持,这表明观察到的下调并非通过从整个细胞群体中选择和消除不适合的细胞而发生。这些数据表明,成骨分化的BMSC和ASC从反映其多能性的多样化基因表达模式转变为专门满足目标谱系要求的配置。这种变化可能有助于使源自不同组织的干细胞混合群体中的基因表达正常化。